Showing results (1-10 of 119) with videos related to
Sort By:
Pageof 12
Current Pharmaceutical Design|May 29, 2003
Central pre-proglucagon derived peptides: opportunities for treatment of obesityPhilip J Larsen, Niels Vrang, Mads Tang-ChristensenBrain Research|April 17, 2007
Characterization of brainstem preproglucagon projections to the paraventricular and dorsomedial hypothalamic nucleiNiels Vrang, Mikkel Hansen, Philip Just Larsen, et al.Brain Research|February 16, 2008
The putative neuropeptide TAFA5 is expressed in the hypothalamic paraventricular nucleus and is regulated by dehydrationSarah Juel Paulsen, Mads Tang Christensen, Niels Vrang, et al.European Journal of Pharmacology|November 19, 2003
Hypothalamic melanocortin neurons integrate signals of energy stateMichael A CowleyActa Pharmacologica Sinica|February 4, 2012
Laboratory animals as surrogate models of human obesityCecilia Nilsson, Kirsten Raun, Fei-fei Yan, et al.Brain Research|February 20, 2003
Hypothalamic cocaine-amphetamine regulated transcript (CART) is regulated by glucocorticoidsNiels Vrang, Philip J Larsen, Mads Tang-Christensen, et al.Current Pharmaceutical Design|May 29, 2003
Ghrelin as a potential anti-obesity targetTamas L Horvath, Tamara Castañeda, Mads Tang-Christensen, et al.American Journal of Physiology. Regulatory, Integrative and Comparative Physiology|August 18, 2006
PYY(3-36) reduces food intake and body weight and improves insulin sensitivity in rodent models of diet-induced obesityNiels Vrang, Andreas Nygaard Madsen, Mads Tang-Christensen, et al.Frontiers in Neuroendocrinology|September 28, 2015
New insights in leptin resistance mechanisms in miceEglantine Balland, Michael A CowleyEndocrinology|July 3, 2004
Central administration of ghrelin and agouti-related protein (83-132) increases food intake and decreases spontaneous locomotor activity in ratsMads Tang-Christensen, Niels Vrang, Sylvia Ortmann, et al.Pageof 12